Marc Semigran - 17 Aug 2023 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Chief Development Officer
Signature
/s/ John R. Moore, Attorney-in-Fact for Semigran Marc
Issuer symbol
EWTX
Transactions as of
17 Aug 2023
Net transactions value
$0
Form type
4
Filing time
18 Aug 2023, 19:13:10 UTC
Previous filing
03 Jan 2023
Next filing
14 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +133,333 $0.000000 133,333 17 Aug 2023 Common Stock 133,333 $7.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date.